Sinotherapeutics Inc. A (688247) — Financial Flexibility Index
Sinotherapeutics Inc. A (688247) has a Financial Flexibility Index of 0.94x as of December 2025. Free cash flow of CN¥136.88 Million (operating CF CN¥95.33 Million minus capex CN¥41.56 Million) represents 1% of total liabilities (CN¥146.12 Million). Also explore Sinotherapeutics Inc. A (688247) net asset momentum to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sinotherapeutics Inc. A Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Sinotherapeutics Inc. A across 6 annual periods. Check Sinotherapeutics Inc. A asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Annual Financial Flexibility Index for Sinotherapeutics Inc. A (2020–2025)
Year-by-year free cash flow to debt coverage for Sinotherapeutics Inc. A. For the full company profile including market capitalisation, see Sinotherapeutics Inc. A (688247) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.94x | CN¥136.88 Million | CN¥95.33 Million | CN¥146.12 Million | ▼ -25.0% |
| 2024 | 1.25x | CN¥225.16 Million | CN¥130.23 Million | CN¥180.30 Million | ▲ +264.1% |
| 2023 | 0.34x | CN¥51.91 Million | CN¥12.96 Million | CN¥151.36 Million | ▼ -78.7% |
| 2022 | 1.61x | CN¥249.52 Million | CN¥73.18 Million | CN¥155.05 Million | ▲ +59.8% |
| 2021 | 1.01x | CN¥161.78 Million | CN¥145.77 Million | CN¥160.62 Million | ▼ -26.7% |
| 2020 | 1.37x | CN¥248.38 Million | CN¥210.04 Million | CN¥180.76 Million | — |